Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

What symbol and exchange does Mobia Medical shares trade?

Mobia Medical trades on the NASDAQ stock market under the symbol MOBI.

What is Mobia Medical stock price doing today?

As of November 11, 2026, MOBI stock price climbed to $13.47 with 269,987 million shares trading.

What is Mobia Medical's Beta?

MOBI has a beta of 0.43, meaning it tends to be less sensitive to market movements. MOBI has a correlation of 0.00 to the broad based SPY ETF.

How much is Mobia Medical worth?

MOBI has a market cap of $448.43 million. This is considered a Small Cap stock.

How much money does Mobia Medical make?

Last quarter Mobia Medical reported $16 million in Revenue and -$.52 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.08.

What are the top ETFs holding Mobia Medical?

The top ETF exchange traded funds that MOBI belongs to (by Net Assets): VTI, IWM, VXF, IWO, SCHA.

What are the support and resistance levels for Mobia Medical (MOBI)?

MOBI support price is $11.43 and resistance is $12.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MOBI shares will trade within this expected range on the day.